ArticleJournal of clinical pharmacology2019

Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study.

Heino Stass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.